INDUCTION CHEMOTHERAPY IN HEAD AND NECK-CANCER WITH CISPLATINUM (C), 5 FLUORO URACIL (F), BLEOMYCIN (B) OR C+

被引：0
|
作者：
BASSOT, F
BRASNU, D
STGUILLY, L
MENARD, M
FABRE, A
DONNADIEU, S
LACCOURREYE, H
JACQUILLAT, C
机构：
[1] HOP SALPETRIERE,DEPT ONCOL,F-75651 PARIS 13,FRANCE
[2] HOP LAENNEC,DEPT HEAD & NECK SURG,F-75340 PARIS 07,FRANCE
来源：
CANCER DRUG DELIVERY | 1986年 / 3卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [21] TOXICITY OF AGGRESSIVE MULTIMODALITY THERAPY INCLUDING CISPLATINUM, BLEOMYCIN AND METHOTREXATE WITH RADIATION AND OR SURGERY FOR ADVANCED HEAD AND NECK-CANCER
    WEICHSELBAUM, RR
    POSNER, MR
    ERVIN, TJ
    FABIAN, RL
    MILLER, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (05): : 909 - 913
  • [22] CISPLATIN AND MITOGUAZONE - AN INDUCTION CHEMOTHERAPY REGIMEN IN ADVANCED HEAD AND NECK-CANCER
    FORASTIERE, AA
    PERRY, DJ
    WOLF, GT
    WHEELER, RH
    NATALE, RB
    CANCER, 1988, 62 (11) : 2304 - 2308
  • [23] BLEOMYCIN (B) INFUSION WITH CYCLOPHOSPHAMIDE (C), METHOTREXATE (M) AND 5-FLUOROURACIL (F) IN PREVIOUSLY IRRADIATED HEAD AND NECK CANCER
    CORTES, EP
    AMIN, VC
    KHAFIF, R
    ATTIE, J
    EISENBUD, L
    WOLK, D
    ARAL, I
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 140 - 140
  • [24] COMBINATION CHEMOTHERAPY AS INDUCTION THERAPY FOR ADVANCED RESECTABLE HEAD AND NECK-CANCER
    MAIPANG, T
    MAIPANG, M
    GEATER, A
    PANJAPIYAKUL, C
    WATANAAREPORNCHAI, S
    PUNPERK, S
    JOURNAL OF SURGICAL ONCOLOGY, 1995, 59 (02) : 80 - 85
  • [25] COMBINATION OF LOW-DOSE BLEOMYCIN (BLEO) FOLLOWED BY CYCLOPHOSPHAMIDE (C), METHOTREXATE (M) AND 5-FLUOROURACIL (F) FOR ADVANCED HEAD AND NECK-CANCER
    CORTES, EP
    AMIN, VC
    ATTIE, J
    EISENBUD, L
    KHAFIF, R
    WOLK, D
    ARAL, I
    SCIUBBA, J
    AKBIYIK, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 259 - 259
  • [26] COMBINATION CHEMOTHERAPY WITH BLEOMYCIN (BLEO) AND HYDROXYUREA (HU) IN THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER
    EISENBERGER, M
    DENEFRIO, JM
    KAPLAN, DL
    SILVERMAN, M
    LESSNER, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 343 - 343
  • [27] CISPLATIN, BLEOMYCIN, AND METHOTREXATE (PBM) CHEMOTHERAPY IN LOCALLY ADVANCED AND METASTATIC HEAD AND NECK-CANCER
    UZIELY, B
    PERETZ, T
    SULKES, A
    FEIGIN, E
    ISACSON, R
    BIRAN, S
    JOURNAL OF SURGICAL ONCOLOGY, 1989, 42 (04) : 234 - 238
  • [28] COMBINED MODALITY TREATMENT OF HEAD AND NECK-CANCER WITH CISPLATIN, BLEOMYCIN, METHOTREXATE LEUCOVORIN CHEMOTHERAPY
    WEICHSELBAUM, RR
    CLARK, JR
    MILLER, D
    POSNER, MR
    ERVIN, TJ
    CANCER, 1985, 55 (09) : 2149 - 2155
  • [29] SEQUENTIAL ADMINISTRATION OF METHOTREXATE AND 5 FLUORO-URACIL IN SQUAMOUS-CELL HEAD AND NECK-CANCER - RESULTS OF A PROSPECTIVE TRIAL
    CHEVALLIER, B
    LEFUR, R
    DEHESDIN, D
    BASTIT, P
    SENG, SH
    BULLETIN DU CANCER, 1986, 73 (06) : 680 - 682
  • [30] THE EFFECT OF DELAYING STANDARD TREATMENT FOR INDUCTION CHEMOTHERAPY IN ADVANCED HEAD AND NECK-CANCER
    HAAS, JS
    TOOHILL, RJ
    HAAS, CD
    WILSON, JF
    BYHARDT, RW
    RITCH, PS
    GROSSMAN, TW
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (02): : 116 - 116
12345